On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus
Open Access
- 3 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 217 (2), 238-244
- https://doi.org/10.1093/infdis/jix575
Abstract
While circulation of respiratory syncytial virus (RSV) results in high rates of hospitalization, particularly among young children and elderly individuals, little is known about the role of different age groups in propagating annual RSV epidemics. We evaluate the roles played by individuals in different age groups during RSV epidemics in the United States between 2001 and 2012, using the previously defined relative risk (RR) statistic estimated from the hospitalization data from the Healthcare Cost and Utilization Project. Transmission modeling was used to examine the robustness of our inference method. Children aged 3–4 years and 5–6 years each had the highest RR estimate for 5 of 11 seasons included in this study, with RSV hospitalization rates in infants being generally higher during seasons when children aged 5–6 years had the highest RR estimate. Children aged 2 years had the highest RR estimate during one season. RR estimates in infants and individuals aged ≥11 years were mostly lower than in children aged 1–10 years. Highest RR values aligned with groups for which vaccination had the largest impact on epidemic dynamics in most model simulations. Our estimates suggest the prominent relative roles of children aged ≤10 years (particularly among those aged 3–6 years) in propagating RSV epidemics. These results, combined with further modeling work, should help inform RSV vaccination policies.Keywords
Other Versions
Funding Information
- National Institutes of Health
- National Institute of General Medical Sciences
- Fogarty International Center
This publication has 22 references indexed in Scilit:
- Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus InfectionEBioMedicine, 2017
- Temporally Varying Relative Risks for Infectious DiseasesEpidemiology, 2017
- Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country SettingPLOS ONE, 2015
- Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011Influenza and Other Respiratory Viruses, 2015
- Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trialsInfluenza and Other Respiratory Viruses, 2015
- On the relative role of different age groups in influenza epidemicsEpidemics, 2015
- Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized ProblemDrugs & Aging, 2015
- The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infantsVaccine, 2014
- Bronchiolitis and Respiratory Syncytial VirusArchives of Pediatrics & Adolescent Medicine, 2009
- Respiratory syncytial virus bronchiolitis: prevention and treatmentExpert Opinion on Pharmacotherapy, 2008